Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ruchi Pandey
Observed name:
R. Pandey
Institutions:
Indiana University Indianapolis,
Indiana University School of Medicine
Observed institutions:
Washington University in St. Louis,
University of Michigan,
Indiana University Indianapolis,
Indiana University School of Medicine,
Indiana University – Purdue University Indianapolis
ORCID:
0000-0002-7846-7415
Observed ORCID:
0000-0002-7846-7415
OpenAlex ID:
A5068395011
Inhibition of Inflammatory Signaling in Tet2 Mutant Preleukemic Cells Mitigates Stress-Induced Abnormalities and Clonal Hematopoiesis
2018
·
Zhigang Cai
, Jonathan J. Kotzin
, et al.
·
Cell stem cell
·
420
PDF
The Histone Acetyltransferase MOF Is a Key Regulator of the Embryonic Stem Cell Core Transcriptional Network
2012
·
Xiangzhi Li
, Li Li
, et al.
·
Cell stem cell
·
205
PDF
Role of SHP2 in hematopoiesis and leukemogenesis
2017
·
Ruchi Pandey
, Mallika Saxena
, et al.
·
Current Opinion in Hematology
·
77
RAG-mediated DNA double-strand breaks activate a cell type–specific checkpoint to inhibit pre–B cell receptor signals
2016
·
Jeffrey J. Bednarski
, Ruchi Pandey
, et al.
·
The Journal of Experimental Medicine
·
52
PDF
SHP2 inhibition reduces leukemogenesis in models of combined genetic and epigenetic mutations
2019
·
Ruchi Pandey
, Baskar Ramdas
, et al.
·
Journal of Clinical Investigation
·
33
PDF
Targeting phosphatidylinositol-3-kinase pathway for the treatment of Philadelphia-negative myeloproliferative neoplasms
2015
·
Ruchi Pandey
, Reuben Kapur
·
Molecular Cancer
·
20
PDF
Driver Mutations in Leukemia Promote Disease Pathogenesis through a Combination of Cell-Autonomous and Niche Modulation
2020
·
Baskar Ramdas
, Raghuveer Singh Mali
, et al.
·
Stem Cell Reports
·
16
PDF
H2A.Z Sets the Stage in ESCs
2013
·
Ruchi Pandey
, Yali Dou
·
Cell stem cell
·
11
PDF
Alkynyl nicotinamides show antileukemic activity in drug-resistant acute myeloid leukemia
2024
·
Baskar Ramdas
, Neetu Dayal
, et al.
·
Journal of Clinical Investigation
·
4
Kinase inhibitors in clinical practice: An expanding world
2017
·
Ruchi Pandey
, Reuben Kapur
·
Journal of Allergy and Clinical Immunology
·
4
Role of LIM Kinase in Oncogenic Signaling from FLT3 and KIT Receptors and Its Targeting in Myeloid Leukemia
2015
·
Ruchi Pandey
, Raghuveer Mali
, et al.
·
Blood
·
3
DNA damage on the DOCK in FLT3-ITD-driven acute myeloid leukemia
2019
·
Ruchi Pandey
, Reuben Kapur
·
Haematologica
·
2
PDF
Downregulation of Morrbid in Tet2-Deficient Preleukemic Cells Overcomes Resistance to Inflammatory Stress and Mitigates Clonal Hematopoiesis
2018
·
Zhigang Cai
, Jonathan Kotzin
, et al.
·
Blood
·
1
RAG-mediated DNA double-strand breaks activate a cell type–specific checkpoint to inhibit pre–B cell receptor signals
2016
·
Jeffrey J. Bednarski
, Ruchi Pandey
, et al.
·
The Journal of Cell Biology
·
1
Novel Mechanisms of Growth Inhibition By Histone Deacetylase Inhibitors in MPN
2015
·
Ruchi Pandey
, Raghuveer Mali
, et al.
·
Blood
·
1
3160 – Alkynyl Nicotinamides With Antileukemic Activity for Treating Poor Prognosis Aml
2023
·
Baskar Ramdas
, Neetu Dayal
, et al.
·
Experimental Hematology
Combined Heterozygous Loss of Tet2 and Dnmt3a Along with Expression of Flt3ITD/WT results in Acute Myeloid Leukemia Which Responds to a Combination of FLT3 Inhibitor, APE1 Inhibitor and Decitabine
2019
·
Baskar Ramdas
, Lakshmi Reddy Palam
, et al.
·
Blood
Flow cytometric bead assay of BCR-ABL fusion proteins in leukemia patients: An Indian experience.
2010
·
R. Pandey
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
18
Citation count:
850
H-index:
8
I10-index:
8
Year
Topic
Type